NCT04164901
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04164901 |
| Title | Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | Yes |
| Sponsors | Agios Pharmaceuticals, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | child | adult |
| Covered Countries | USA | NLD | ITA | ISR | GBR | FRA | ESP | DEU | CHE | CAN |
CKB BOOST